AVNS logo

Avanos Medical (AVNS) EBITDA

Annual EBITDA

$53.20 M
-$69.70 M-56.71%

December 31, 2023

Summary

Performance

1-Year Change

-56.71%

3-Year Change

+2760%

5-Year Change

+27.27%

15-Year Change

+181.48%

AVNS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.44%
AVNS annual EBITDA is higher than 85.44% of companies in Healthcare sector

High & Low

All-time High

$297.10 M
AVNS annual EBITDA is currently -82.09% below its historical high of $297.10 million

3-Year Low

$48.90 M
AVNS annual EBITDA is currently +8.79% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AVNS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 20, 2025
AVNS next annual earnings announcement is scheduled for Feb 20, 2025

OtherAVNSprofitabilitymetrics:

Annual Revenue

$673.30 M
AVNS annual revenue is $673.30 million

Annual Net Income

-$61.80 M
AVNS annual net profit is -$61.80 million

Annual EBIT

$7.10 M
AVNS annual earnings before interest & taxes is $7.10 million

Annual EPS

-$1.32
AVNS annual earnings per share is -$1.32

Quarterly EBITDA

$24.40 M
+$3.80 M+18.45%

September 30, 2024

Summary

Performance

3-Month Change

+18.45%

1-Year Change

+86.26%

3-Year Change

+23.86%

5-Year Change

+23.86%

AVNS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.34%
AVNS quarterly EBITDA is higher than 85.34% of companies in Healthcare sector

High & Low

All-time High

$279.40 M
AVNS quarterly EBITDA is currently -91.27% below its historical high of $279.40 million

3-Year Low

-$12.90 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AVNS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 20, 2025
AVNS next earnings announcement is scheduled for Feb 20, 2025

OtherAVNSprofitabilitymetrics:

Quarterly Revenue

$170.40 M
AVNS quarterly revenue is $170.40 million

Quarterly Net Income

$4.30 M
AVNS quarterly net profit is $4.30 million

Quarterly EBIT

$12.70 M
AVNS quarterly earnings before interest & taxes is $12.70 million

Quarterly EPS

$0.09
AVNS quarterly earnings per share is $0.09

TTM EBITDA

$84.70 M
+$11.30 M+15.40%

September 30, 2024

Summary

Performance

3-Month Change

+15.4%

1-Year Change

+40.7%

3-Year Change

+281.53%

5-Year Change

+281.53%

AVNS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.27%
AVNS TTM EBITDA is higher than 86.27% of companies in Healthcare sector

High & Low

All-time High

$399.90 M
AVNS TTM EBITDA is currently -78.82% below its historical high of $399.90 million

3-Year Low

-$200.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AVNS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 20, 2025
AVNS next earnings announcement is scheduled for Feb 20, 2025

OtherAVNSprofitabilitymetrics:

TTM Revenue

$681.50 M
AVNS TTM revenue is $681.50 million

TTM Net Income

$15.70 M
AVNS TTM net profit is $15.70 million

TTM EBIT

$38.80 M
AVNS TTM earnings before interest & taxes is $38.80 million

TTM EPS

$0.34
AVNS TTM earnings per share is $0.34

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$53.20 M
AVNS annual EBITDA is $53.20 million

Annual Net Income

-$61.80 M
AVNS annual net profit is -$61.80 million

Annual Interest Expense

$15.00 M
AVNS annual interest expense is $15.00 million

Annual Income Tax

$2.00 M
AVNS annual income tax is $2.00 million

Annual D&A

$46.10 M
AVNS annual depreciation & amortization is $46.10 million

AVNS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-56.7%+86.3%+40.7%
3 y3 years+2760.0%+23.9%+281.5%
5 y5 years+27.3%+23.9%+281.5%

AVNS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-56.7%+8.8%-20.5%+289.1%-12.7%>+9999.0%
5 y5-year-56.7%+539.7%-20.5%+172.0%-12.7%+458.9%
alltimeall time-82.1%+176.0%-91.3%+105.5%-78.8%+128.1%

Avanos Medical EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$24.40 M(+18.4%)
$84.70 M(+15.4%)
Jun 2024
-
$20.60 M(+28.7%)
$73.40 M(+17.1%)
Mar 2024
-
$16.00 M(-32.5%)
$62.70 M(+17.9%)
Dec 2023
$53.20 M(-56.7%)
$23.70 M(+80.9%)
$53.20 M(-11.6%)
Sep 2023
-
$13.10 M(+32.3%)
$60.20 M(-16.2%)
Jun 2023
-
$9.90 M(+52.3%)
$71.80 M(-14.3%)
Mar 2023
-
$6.50 M(-78.8%)
$83.80 M(-13.6%)
Dec 2022
$122.90 M(+151.3%)
$30.70 M(+24.3%)
$97.00 M(+81.6%)
Sep 2022
-
$24.70 M(+12.8%)
$53.40 M(+27.4%)
Jun 2022
-
$21.90 M(+11.2%)
$41.90 M(+88.7%)
Mar 2022
-
$19.70 M(-252.7%)
$22.20 M(<-9900.0%)
Dec 2021
$48.90 M(-2545.0%)
-$12.90 M(-197.7%)
-$200.00 K(-99.1%)
Sep 2021
-
$13.20 M(+500.0%)
-$21.20 M(-10.2%)
Jun 2021
-
$2.20 M(-181.5%)
-$23.60 M(+42.2%)
Mar 2021
-
-$2.70 M(-92.0%)
-$16.60 M(+730.0%)
Dec 2020
-$2.00 M(-83.5%)
-$33.90 M(-413.9%)
-$2.00 M(-104.9%)
Sep 2020
-
$10.80 M(+17.4%)
$41.00 M(+85.5%)
Jun 2020
-
$9.20 M(-22.7%)
$22.10 M(+62.5%)
Mar 2020
-
$11.90 M(+30.8%)
$13.60 M(-212.4%)
Dec 2019
-$12.10 M(-128.9%)
$9.10 M(-212.3%)
-$12.10 M(-33.1%)
Sep 2019
-
-$8.10 M(-1257.1%)
-$18.10 M(-323.5%)
Jun 2019
-
$700.00 K(-105.1%)
$8.10 M(-69.1%)
Mar 2019
-
-$13.80 M(-545.2%)
$26.20 M(-37.3%)
Dec 2018
$41.80 M
$3.10 M(-82.9%)
$41.80 M(-12.2%)
DateAnnualQuarterlyTTM
Sep 2018
-
$18.10 M(-3.7%)
$47.60 M(+32.6%)
Jun 2018
-
$18.80 M(+944.4%)
$35.90 M(+65.4%)
Mar 2018
-
$1.80 M(-79.8%)
$21.70 M(+14.8%)
Dec 2017
$18.90 M(-145.8%)
$8.90 M(+39.1%)
$18.90 M(-112.5%)
Sep 2017
-
$6.40 M(+39.1%)
-$151.80 M(+26.0%)
Jun 2017
-
$4.60 M(-560.0%)
-$120.50 M(+32.1%)
Mar 2017
-
-$1.00 M(-99.4%)
-$91.20 M(+120.8%)
Dec 2016
-$41.30 M(-41.0%)
-$161.80 M(-529.2%)
-$41.30 M(-110.3%)
Sep 2016
-
$37.70 M(+11.2%)
$399.90 M(-583.6%)
Jun 2016
-
$33.90 M(-30.7%)
-$82.70 M(+5.4%)
Mar 2016
-
$48.90 M(-82.5%)
-$78.50 M(+12.1%)
Dec 2015
-$70.00 M(-138.3%)
$279.40 M(-162.8%)
-$70.00 M(-76.8%)
Sep 2015
-
-$444.90 M(-1267.7%)
-$301.60 M(-263.7%)
Jun 2015
-
$38.10 M(-33.6%)
$184.20 M(+15.1%)
Mar 2015
-
$57.40 M(+20.1%)
$160.00 M(-12.4%)
Dec 2014
$182.60 M(-38.5%)
$47.80 M(+16.9%)
$182.60 M(-13.0%)
Sep 2014
-
$40.90 M(+194.2%)
$209.80 M(-18.3%)
Jun 2014
-
$13.90 M(-82.6%)
$256.70 M(-19.1%)
Mar 2014
-
$80.00 M(+6.7%)
$317.40 M(+6.8%)
Dec 2013
$297.10 M(+3.1%)
$75.00 M(-14.6%)
$297.10 M(+33.8%)
Sep 2013
-
$87.80 M(+17.7%)
$222.10 M(+65.4%)
Jun 2013
-
$74.60 M(+25.0%)
$134.30 M(+125.0%)
Mar 2013
-
$59.70 M
$59.70 M
Dec 2012
$288.20 M(+8.4%)
-
-
Dec 2011
$265.90 M
-
-

FAQ

  • What is Avanos Medical annual EBITDA?
  • What is the all time high annual EBITDA for Avanos Medical?
  • What is Avanos Medical annual EBITDA year-on-year change?
  • What is Avanos Medical quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Avanos Medical?
  • What is Avanos Medical quarterly EBITDA year-on-year change?
  • What is Avanos Medical TTM EBITDA?
  • What is the all time high TTM EBITDA for Avanos Medical?
  • What is Avanos Medical TTM EBITDA year-on-year change?

What is Avanos Medical annual EBITDA?

The current annual EBITDA of AVNS is $53.20 M

What is the all time high annual EBITDA for Avanos Medical?

Avanos Medical all-time high annual EBITDA is $297.10 M

What is Avanos Medical annual EBITDA year-on-year change?

Over the past year, AVNS annual EBITDA has changed by -$69.70 M (-56.71%)

What is Avanos Medical quarterly EBITDA?

The current quarterly EBITDA of AVNS is $24.40 M

What is the all time high quarterly EBITDA for Avanos Medical?

Avanos Medical all-time high quarterly EBITDA is $279.40 M

What is Avanos Medical quarterly EBITDA year-on-year change?

Over the past year, AVNS quarterly EBITDA has changed by +$11.30 M (+86.26%)

What is Avanos Medical TTM EBITDA?

The current TTM EBITDA of AVNS is $84.70 M

What is the all time high TTM EBITDA for Avanos Medical?

Avanos Medical all-time high TTM EBITDA is $399.90 M

What is Avanos Medical TTM EBITDA year-on-year change?

Over the past year, AVNS TTM EBITDA has changed by +$24.50 M (+40.70%)